Clinical Trials Browser

INDUSTRY × Observational × Everolimus × Clear all

NCT02184416 2026-02-27

ADONIS

Carcinoma, Renal Cell

NCT02264665 2023-11-13

OPALINE

144 enrolled 26 charts

Adenoma, Islet Cell

NCT01390519 2016-01-13

OSAT

Carcinoma, Renal Cell

NCT02023359 2015-12-29

Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer

Breast Neoplasms